No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Amiodarone / therapeutic use
-
Anti-Arrhythmia Agents / therapeutic use
-
Arrhythmias, Cardiac / drug therapy
-
Arrhythmias, Cardiac / prevention & control
-
Arrhythmias, Cardiac / therapy
-
Cardiomyopathies / diagnosis*
-
Cardiomyopathies / mortality
-
Cardiomyopathies / physiopathology
-
Cardiomyopathies / therapy*
-
Clinical Trials as Topic
-
Defibrillators, Implantable
-
Electrophysiology
-
Female
-
Follow-Up Studies
-
Hemodynamics
-
Humans
-
Male
-
Meta-Analysis as Topic
-
Myocardial Infarction / etiology
-
Myocardial Infarction / prevention & control
-
Primary Prevention
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Risk Factors
-
Sotalol / therapeutic use
-
Time Factors
-
Vasodilator Agents / therapeutic use
Substances
-
Adrenergic beta-Antagonists
-
Anti-Arrhythmia Agents
-
Vasodilator Agents
-
Sotalol
-
Amiodarone